National PBM Monograph Template Rev20091005

Active URTI or other respiratory condition affecting intranasal absorption or assessment of Adverse Events. Any intranasal products 24h before study; GI bleed disorders. Pregnant/ Breastfeeding Immediate post-op (day 0): If VAS-PI≥40, then given dose intranasal DRUG. IN DRUG = Ketorolac 30mg, or placebo. Morphine sulfate PCA backup. Day 1 ................
................